• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human 5-oxoprolinase (OPLAH), Truncated

ACP21404

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP21404 Target NameOPLAH
Target Synonyms5 Opase; 5 oxo L prolinase; 5 oxoprolinase (ATP hydrolysing); 5 oxoprolinase; 5-OPase; 5-oxo-L-prolinase; 5-oxoprolinase; DKFZp434H244; OPLA; OPLA_HUMAN; oplah; OPLAHD; PyroglutamaseFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO14841
Background Information
  • Uniprot Id

    O14841

  • Target Species

    Human

  • Target Name

    OPLAH

  • Target Full Name

    5-oxoprolinase

  • Target Function

    Catalyzes the cleavage of 5-oxo-L-proline to form L-glutamate coupled to the hydrolysis of ATP to ADP and inorganic phosphate.

  • Target Involvement

    5-oxoprolinase deficiency (OPLAHD)

  • Target Protein Families

    Oxoprolinase family

  • Target Research Area

    Metabolism

  • Target Synonyms

    5 Opase; 5 oxo L prolinase; 5 oxoprolinase (ATP hydrolysing); 5 oxoprolinase; 5-OPase; 5-oxo-L-prolinase; 5-oxoprolinase; DKFZp434H244; OPLA; OPLA_HUMAN; oplah; OPLAHD; Pyroglutamase

  • Target Background

    The protein encoded by this gene acts as a homodimer, using ATP hydrolysis to catalyze the conversion of 5-oxo-L-proline to L-glutamate. Defects in this gene are a cause of 5-oxoprolinase deficiency (OPLAHD).

Inquire Recombinant Human 5-oxoprolinase (OPLAH), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification